Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02693522Phase 3Completed
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by Daewoong Pharmaceutical. Started Oct 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02693522.